Advertisement
Advertisement
Study decoded · health · Emerging
Plant Compound Umbelliferone Kills Breast Cancer Cells In Lab Dish Study
Lab dish study only492 µM killed half of cellsNormal cells largely sparedNot tested in humans
A natural plant compound called umbelliferone reduced the viability of MCF-7 breast cancer cells in a lab dish study published in Pharmaceuticals, with half of cancer cells dying at a concentration of 492 micromolar after 24 hours, while normal cells tolerated far higher doses.
Researchers tested umbelliferone, a coumarin compound found in plants such as carrots, coriander and various herbs, against MCF-7 human breast cancer cells grown in lab dishes. After 24 hours, the compound reduced cancer cell viability in a dose-dependent way, with an IC50 of 492 micromolar, meaning that concentration killed half the cancer cells. In normal BJ fibroblast cells, viability never dropped below 50% even at doses up to 1400 micromolar, giving a selectivity index greater than 2.85, meaning the compound needed roughly three times the concentration to harm normal cells compared to cancer cells. A test called Annexin V-FITC/PI analysis, which detects cells in the process of programmed cell death, found a higher share of cancer cells undergoing apoptosis at 800 micromolar. A colony formation test, measuring whether surviving cells grow into new colonies, showed reduced capacity after treatment. At 400 micromolar, the compound raised two apoptosis-signaling enzymes: Caspase-3/7 activity rose to 1.873 times baseline and Caspase-9 rose to 2.483 times baseline. Neither caspase rose significantly at 800 micromolar. Computer modeling predicted umbelliferone interacts with four proteins involved in growth and survival signaling: AKT1, mTOR, PI3K-alpha and Caspase-7.
Caspases are enzymes that act as executioners inside a cell, carrying out the final steps of programmed cell death once a cell receives signals that it's damaged. The rise in Caspase-3/7 and Caspase-9 at 400 micromolar suggests umbelliferone pushed cancer cells toward that self-destruct pathway at that dose, an effect that did not hold at 800 micromolar. The computer modeling predicted umbelliferone might interact with growth-and-survival proteins, but the authors state these computational findings are hypothesis-generating and do not establish that the compound engages those targets inside a living cell.
Caspase Activity Rose at 400 µM: Caspase-9 to 2.483x, Caspase-3/7 to 1.873x Baseline
Data Panel
- Who
- MCF-7 human breast cancer cells and BJ normal human fibroblast cells, lab dish study
- Design
- In vitro dose-response study with molecular docking and molecular dynamics simulations; single cell line comparison
- Dose
- Umbelliferone tested across a concentration range; key doses were 400 µM, 492 µM (IC50) and 800 µM, exposure duration 24 hours
- Primary result
- IC50 of 492 µM in MCF-7 cancer cells after 24 hours versus IC50 greater than 1400 µM in normal fibroblasts; selectivity index greater than 2.85
- Secondary
- At 400 µM, Caspase-3/7 activity rose to 1.873 times baseline and Caspase-9 rose to 2.483 times baseline; total apoptosis significantly increased at 800 µM; colony formation capacity reduced after treatment
- Funding / conflicts
- Not reported
This is a lab-dish study using one cancer cell line and one normal cell line, with no animal or human data, so these concentrations cannot be assumed to occur in a living body. Funding and conflicts were not reported in the available record.
Dr. Axe's Take
Umbelliferone shows up in carrots, coriander and bitter orange peel, and selective toxicity toward cancer cells over normal cells in this lab dish is a finding worth tracking, not a treatment. These are concentrations applied directly to cells in a dish, far beyond what food or a supplement delivers, and nobody has shown this works in an animal or a person yet. If you or someone you love is dealing with breast cancer, keep working with your oncology team exactly as prescribed; this is a lab finding, not a treatment yet. I view results like this as a reason to stay curious about plant compounds while waiting for animal data before calling it clinically meaningful.
— Dr. AxeDr. Axe Quiz